-
Comparison of TEG Parameters Between Clopidogrel-resistant Resistant and Non-resistant Groups. Ann. Surg. (IF 7.5) Pub Date : 2025-05-29
Adriana A Rodriguez Alvarez,Isabella Ferlini Cieri,Mounika Naidu Boya,Sasha Suarez Ferreira,Shiv Patel,Jeongin Jang,Kellie Machlus,Anahita DuaOBJECTIVE Compare TEG parameters between clopidogrel-resistant and clopidogrel-non-resistant groups. SUMMARY BACKGROUND DATA Graft or stent thrombosis affects 1 in 5 patients within six months post-revascularization and is a leading cause of amputation in the elderly. Clopidogrel resistance occurs in 5-44% of patients. METHODS This prospective observational study evaluated patients with PAD undergoing
-
Rethinking Local Therapy for Rectal Cancer in the Era of Precision Oncology-When Less Is More. JAMA Surg. (IF 15.7) Pub Date : 2025-05-28
Aron Bercz,Philip S Bauer,J Joshua Smith -
Association of Familiarity of the Surgeon-Anesthesiologist Dyad With Major Morbidity After Surgery. JAMA Surg. (IF 15.7) Pub Date : 2025-05-28
Jasmine Hwang,Rachel R Kelz -
Tracheobronchial Replacement JAMA Surg. (IF 15.7) Pub Date : 2025-05-28
Emmanuel Martinod, Dana M. Radu, Ilaria Onorati, Xavier Chapalain, Ana Maria Santos Portela, Marine Peretti, Olivia Freynet, Yurdagül Uzunhan, Kader Chouahnia, Boris Duchemann, Charles Juvin, Guillaume Lebreton, Hélène Rouard, Guillaume Van der Meersch, Geraud Galvaing, Jean-Baptiste Chadeyras, François Tronc, Paulina Kuczma, Christophe Trésallet, Nicolas Vénissac, Sadek Beloucif, Olivier Huet, EricImportanceTracheobronchial replacement remains a surgical and biological challenge despite several decades of experimental and clinical research.ObjectiveTo compile a comprehensive state-of-the-science review examining the current indications, techniques, and outcomes of tracheobronchial replacement in human patients.Evidence ReviewA systematic review of the literature was conducted on July 1, 2024
-
Hospital Ownership and Surgical Outcomes in East, Central, and Southern Africa JAMA Surg. (IF 15.7) Pub Date : 2025-05-28
Robert K. Parker, Yves Yankunze, Andrea S. Parker, Eric O’Flynn, Niraj Bachheta, Abebe Bekele, Michael M. MwachiroImportanceSurgical mortality remains a critical public health issue in resource-limited settings. Hospital ownership type may influence surgical outcomes, yet this relationship is not well understood in East, Central, and Southern Africa, where a diverse mix of public, private, and faith-based hospitals provides care.ObjectiveTo determine whether hospital ownership type (public, private, or faith-based)
-
Familiarity of the Surgeon-Anesthesiologist Dyad and Major Morbidity After High-Risk Elective Surgery JAMA Surg. (IF 15.7) Pub Date : 2025-05-28
Julie Hallet, Angela Jerath, Pablo Perez d’Empaire, François Carrier, Alexis F. Turgeon, Daniel I. McIsaac, Chris Idestrup, Gianni Lorello, Alana Flexman, Biniam Kidane, Wing C. Chan, Anna Gombay, Natalie Coburn, Antoine Eskander, Rinku SutradharImportanceThe surgeon-anesthesiologist teamwork is a core component of performance in the operating room, which can influence patient outcomes.ObjectiveTo examine the association between surgeon-anesthesiologist dyad familiarity (as dyad volume, the number of procedures done together) with 90-day postoperative major morbidity for high-risk elective surgery.Design, Setting, and ParticipantsThis population-based
-
Can Women Surgeons Have It All? If Not Now, When? Ann. Surg. (IF 7.5) Pub Date : 2025-05-28
Heather A Lillemoe,Rebecca A Snyder -
Being Waitlisted is not Enough-Identification of Pseudo-access to Kidney Transplantation in the United States. Ann. Surg. (IF 7.5) Pub Date : 2025-05-28
Lauren E Matevish,Madhukar S Patel,Deepa Ravindra,Jigesh A Shah,David Wojciechowski,Herbert J Zeh,Parsia A VagefiOBJECTIVE We sought to determine how kidney transplant center volume impacts waitlisted candidate access to transplant. SUMMARY BACKGROUND DATA Over 90,000 candidates await a kidney transplant, of which we hypothesized that waitlist access is subject to significant program-level variation, potentially resulting in pseudo-access: a state where the waitlisted candidate does not achieve expected transplantation
-
The Road from NIH-training Grants for Surgeons: What is the Return on Investment? Ann. Surg. (IF 7.5) Pub Date : 2025-05-28
Lindsay A Demblowski,Carolina Larrain,Anna Coxen,Helina Somervell,Hyoyoung Choo-Wosoba,Seth M Steinberg,Martha A ZeigerOBJECTIVE This study examines the success of surgeon-scientists to non-surgeon physician-scientists in obtaining NIH funding after participation on a research training grant. SUMMARY BACKGROUND DATA Dedicated research time during postgraduate training for physician-scientists is advantageous for obtaining future independent funding from NIH. METHODS NIH Reporter was used to identify F32 and T32 grants
-
The transplant community braces for death by preventable infectious diseases. Am. J. Transplant. (IF 8.9) Pub Date : 2025-06-01
Lara C Pullen -
Unexpected incidental finding in a prospective living kidney donor. Am. J. Transplant. (IF 8.9) Pub Date : 2025-06-01
Vincenzo Villani,Rupak D Kulkarni -
Repeat versus Single Quadratus Lumborum Block to Reduce Opioids After Open Pancreatectomy (RESQU-BLOCK): A Randomized Clinical Trial. Ann. Surg. (IF 7.5) Pub Date : 2025-05-27
Brittany C Fields,Jose M Soliz,Barbra Bryce Speer,Shannon Hancher-Hodges,Keyuri U Popat,Semhar J Ghebremichael,Antoinette Van Meter,Uduak U Williams,Xuemei Wang,Hyunsoo Hwang,Morgan L Bruno,Whitney L Dewhurst,Elsa M Arvide,Naruhiko Ikoma,Jessica E Maxwell,Michael P Kim,Matthew H G Katz,Ching-Wei D Tzeng,Timothy E NewhookOBJECTIVE The primary aim was to compare the proportion of opioid-free discharges between two postoperative analgesia bundles distinguished by receipt of a single-block versus a second, "rescue" block. Secondary outcomes included differences in discharge prescription oral morphine equivalents (OME) and patient-reported outcomes. SUMMARY BACKGROUND After a preoperative quadratus lumborum (QL) block
-
A Systematic Review and Meta-analysis of the Efficacy and Safety of Lytic and Non-lytic Early Thrombus Removal Technologies for Iliofemoral Deep Vein Thrombosis. Ann. Surg. (IF 7.5) Pub Date : 2025-05-27
Benedict R H Turner,Sara Jasionowska,Jessica Shea,Avik Ghosh,Matthew Machin,Adam M Gwozdz,Stephen A Black,Alun H DaviesOBJECTIVES This systematic review and meta-analysis compared the effectiveness and safety of lytic and non-lytic early thrombus removal strategies in addition to anticoagulation versus anticoagulation alone. SUMMARY BACKGROUND DATA Early thrombus removal strategies have been developed to prevent post-thrombotic syndrome (PTS) following acute iliofemoral deep vein thrombosis (DVT). METHODS This review
-
Re: Optimizing the Handling of Missing Data in the UNOS Database. J. Heart Lung Transplant. (IF 6.4) Pub Date : 2025-05-26
William L Baker,Timothy Moore,Eric Baron,Michelle Kittleson,William F Parker,Abhishek Jaiswal -
An open letter to the ISHLT and its global lung transplantation community. J. Heart Lung Transplant. (IF 6.4) Pub Date : 2025-05-26
Paul A Corris,Maria M Crespo,Robin Vos,Sangeeta Bhorade,Scott Palmer,Daniel Chambers -
Graft Survival in Single versus Bilateral Lung Transplantation for Emphysema. Am. J. Transplant. (IF 8.9) Pub Date : 2025-05-24
Darren E Stewart,Jessica M Ruck,Allan B Massie,Dorry L Segev,Melissa B Lesko,Justin C Chan,Stephanie H Chang,Travis C Geraci,Darya Rudym,Mark A Sonnick,Guido Barmaimon,Luis F Angel,Jake G NataliniThe benefits of bilateral lung transplantation (BLT) versus single lung transplantation (SLT) are still debated. One impediment to clinical recommendations is that BLT vs. SLT advantages may vary based on underlying disease. Since both options are clinically tenable in patients with emphysema, we conducted a comprehensive assessment of lung allograft survival in this population. Using U.S. registry
-
Surgical Health Services Research as a Path to Health System Leadership. Ann. Surg. (IF 7.5) Pub Date : 2025-05-23
Kristy K Broman,Rachel Greenup,Lesly A Dossett,Amir Ghaferi -
Cell therapy with human IL-10-producing ILC2s enhances islet function and inhibits allograft rejection. Am. J. Transplant. (IF 8.9) Pub Date : 2025-05-22
Sarah J Colpitts,Sinthuja Jegatheeswaran,Amanda Oakie,Siavash Mashhouri,Nadia Sachewsky,Humaira Murshed,Jessica A Mathews,Kyle T Reid,Paraish S Misra,Vivian C W Fung,Trevor W Reichman,M Cristina Nostro,C Bruce Verchere,Megan K Levings,Sarah Q CromeGroup 2 innate lymphoid cells (ILC2s) that produce IL-10 (IL-10+ILC2s) have demonstrated regulatory and tissue-protective properties in murine studies, but preclinical studies are lacking that explore the potential of human IL-10+ILC2s as a tolerance-promoting cell therapy for transplantation or autoimmunity. Here, we investigated whether human IL-10+ILC2s could enhance islet function and prevent allograft
-
"What's a Win": A Qualitative Study Exploring Surgeon Perspectives on Operative Intent in Non-curative Cancer Surgery. Ann. Surg. (IF 7.5) Pub Date : 2025-05-22
Orly N Farber,Amanda J Reich,Kenneth Williams,Zara Cooper,Jennifer W Mack,George Q Zhang,Tatiana Ramos,Elizabeth J LilleyOBJECTIVE To explore surgeons' perspectives on and priorities for communicating about non-curative operations for patients with advanced cancers, which aim to improve longevity or quality of life without possibility of cure. SUMMARY BACKGROUND DATA Describing the potential benefits of non-curative surgery is important so that treatment decisions are based on an accurate understanding of what surgery
-
Towards an Honest Reflection of Work by HPB Surgeons. Ann. Surg. (IF 7.5) Pub Date : 2025-05-22
Samer A Naffouje,Toms Augustin,Robert Simon,Daniel Joyce,Robert Naples,Anthony Visioni,Kathryn Stackhouse,R Matthew Walsh,Fadi S Dahdaleh -
Clinical Outcomes of Laparoscopic vs Robotic-Assisted Cholecystectomy in Acute Care Surgery JAMA Surg. (IF 15.7) Pub Date : 2025-05-21
Nathnael Abera Woldehana, Andrew Jung, Brett Colton Parker, Alisa Mae Coker, Elliott Richard Haut, Gina Lynn AdralesImportanceThe use of robotic-assisted cholecystectomy in acute care surgery is increasing, but its safety and efficacy compared with laparoscopic cholecystectomy remain unclear.ObjectiveTo compare clinical outcomes and bile duct injury rates between robotic-assisted cholecystectomy and laparoscopic cholecystectomy in acute care surgery.Design, Setting, and ParticipantsThis was a retrospective cohort
-
Mitigating the Blood Pressure Fall With Propofol. JAMA Surg. (IF 15.7) Pub Date : 2025-05-21
Brandi Bottiger,Jessica Zvara,Michael Mazzeffi -
Hemodynamic Impact of Cipepofol vs Propofol During Anesthesia Induction in Patients With Severe Aortic Stenosis JAMA Surg. (IF 15.7) Pub Date : 2025-05-21
Tingting Ni, Xiaoxia Zhou, Shuguang Wu, Tao Lv, Yujiao Hu, Qi Gao, Ge Luo, Chen Xie, Jingcheng Zou, Yuexiu Chen, Linqian Zhao, Jie Xiao, Xincheng Tao, Yu Yi, Zhili Xu, Tingting Wang, Junyu Zhou, Yuanyuan Yao, Min YanImportancePostinduction hemodynamic instability is a frequent complication among patients with severe aortic stenosis (AS). Using cipepofol as the anesthesia agent may reduce the incidence and severity of hemodynamic instability.ObjectiveTo assess whether cipepofol outperforms propofol in maintaining postinduction hemodynamic stability in patients with AS.Design, Setting, and ParticipantsThis single-center
-
Evaluation of the Stability of Organ Procurement Organization Performance Metrics. Am. J. Transplant. (IF 8.9) Pub Date : 2025-05-21
Rocio Lopez,Sumit Mohan,James R Rodrigue,Susana Arrigain,Deena Brosi,Ryan Lavanchy,David Zingmond,Bruce Kaplan,Elizabeth A Pomfret,Jesse D ScholdIn 2020, the Centers for Medicare and Medicaid Services (CMS) updated the Organ Procurement Organization (OPO) Conditions for Coverage, redefining deceased donor potential (DDP) as all inpatient deaths among patients 75 or younger with a primary cause of death consistent with organ donation, also called CALC (Cause, Age, and Location Consistent with donation). This study evaluates CALC performance
-
Impact of Hypovolemic Phlebotomy with Low Central Venous Pressure on Intraoperative Blood Loss in Open Liver Resection: A Double-Blind Randomized Controlled Trial. Ann. Surg. (IF 7.5) Pub Date : 2025-05-21
Warangkana Lapisatepun,Anon Chotirosniramit,Sunhawit Junrungsee,Nutthanun Tungsrirut,Kullakanya Maykanggoon,Phuriphong Chantima,Atipa Nitayamekin,Worakitti LapisatepunOBJECTIVE To assess the efficacy and safety of hypovolemic phlebotomy (HP) versus conventional management (control group) in achieving low central venous pressure (CVP) to reduce blood loss during open liver resections. BACKGROUND Excessive blood loss increases perioperative complications and worsen patient outcomes. HP is used to reduce blood loss and the need for allogenic transfusions. This study
-
Evidence-Based Integration of Environmental Sustainability into Clinical Guidelines for Operating Rooms: A Systematic Review. Ann. Surg. (IF 7.5) Pub Date : 2025-05-21
Kim E van Nieuwenhuizen,Charlotte T J Michels,Ingena G I A Both,Jeroen B Guinée,Frank Willem Jansen,OBJECTIVE To assess the feasibility of integrating environmental sustainability into clinical guidelines for operating rooms (ORs) and provide evidence-based recommendations. SUMMARY BACKGROUND DATA Surgical practices contribute significantly to healthcare's environmental impact. Incorporating sustainability into evidence-based clinical guidelines can support environmentally responsible decision-making
-
MicroRNA Classifier Based on EUS-FNA for the Early Detection of Occult Liver Metastasis in Pancreatic Ductal Adenocarcinoma. Ann. Surg. (IF 7.5) Pub Date : 2025-05-21
Xiulin Hu,Yuting Xie,Shimin Wang,Xiaoju Su,Mengshi Li,Yongpu Feng,Fengyuan Sun,Yang Yang,Jianduo Zhang,Congjia Ma,Mengfan Wang,Kaixuan Wang,Jing Sun,Zhaoshen Li,Xiangyu KongOBJECTIVE This study aimed to investigate whether microRNAs (miRNAs) quantified from primary pancreatic ductal adenocarcinoma (PDAC) samples could serve as potential biomarkers for identifying PDAC with occult liver metastasis. SUMMARY BACKGROUND DATA Undetectable occult liver metastasis impair the survival of PDAC. Novel biomarkers are immediately required to detect occult liver metastasis in PDAC
-
Multistate Model of Chronic Wounds, Amputations, and Mortality: Cohort Study of a State-wide Registry. Ann. Surg. (IF 7.5) Pub Date : 2025-05-21
Joshua S Choi,Manoj Kumar,Andrew R Wilson,Shomita S Mathew-Steiner,Kanhaiya Singh,David J Margolis,Titus K L Schleyer,Chandan K SenOBJECTIVE Use a new patient registry to characterize and predict progression of lower-extremity chronic wounds to amputation and/or death, while considering infection history. BACKGROUND Chronic wounds are a common health issue causing amputation and death. The Regenstrief Chronic Wound Registry, created from one of the U.S.'s largest health information exchanges, can give insights into their epidemiology
-
Specific Congenital Heart Disease Diagnoses Impact Congenital Diaphragmatic Hernia Outcomes: The Heart of the Matter. Ann. Surg. (IF 7.5) Pub Date : 2025-05-20
Kylie I Holden,Ashley H Ebanks,Rebecca A Stark,Yigit S Guner,Terry L Buchmiller,Tim Jancelewicz,Amir M Khan,Anthony Johnson,Kevin P Lally,Damien J LaPar,Matthew T Harting,OBJECTIVE Our objective was to assess outcomes for newborns with congenital diaphragmatic hernia (CDH) and congenital heart disease (CHD). SUMMARY BACKGROUND DATA CDH is a complex malformation often associated with CHD, yet limited data exist on outcomes for infants with both conditions. This study highlights factors associated with survival and how specific cardiac diagnoses shape patient outcomes
-
Novel Benchmark for Robotic Liver Resection - Bridging Tradition with Innovation. Ann. Surg. (IF 7.5) Pub Date : 2025-05-20
Zhihao Li,Matthias Pfister,Dimitri A Raptis,Yong Ma,Guangchao Yang,Linqiang Li,Xuan Song,Guillaume Millet,Stéphanie Truant,Raphael Venezia,Heithem Jeddou,Bastien Le Floch,Alain Valverde,Nicolas Peru,Patrick Pessaux,Fabio Giannone Codiglione,Jean-Yves Mabrut,Kayvan Mohkam,Antonio Sa Cunha,Chady Salloum,Pierre Y Blanc,Bertrand Le Roy,Claire Goumard,Olivier Scatton,Stylianos Tzedakis,David Fuks,IsmaelOBJECTIVE To establish benchmark cutoffs for robotic liver resection (R-LR), encompassing both major and minor resections, and to determine the impact of patient selection on outcomes. BACKGROUND R-LR is a key advancement in minimally invasive liver surgery but lacks standardized benchmarks, especially for minor resections. While guidelines endorse R-LR, its role in optimizing outcomes remains unclear
-
Tacrolimus prolongs corneal allograft survival and prevents dendritic cell infiltration in a myeloid-derived suppressor cell–dependent manner Am. J. Transplant. (IF 8.9) Pub Date : 2025-05-19
Yingyi Liu, Yuerong Ren, Runxi Luo, Xiujuan Li, Limin Xie, Huanmin Kang, Yang Li, Xiaonan Dong, Yan HeTacrolimus (also known as FK506) is one of the most widely used immunosuppressive drugs in the postsurgery management of transplantation. To date, the cellular mechanism by which FK506 suppresses immune activation and elongates allograft survival remains largely unclear. Here, we employed a mouse model for corneal penetrating keratoplasty to interrogate this critical question. Administration of FK506
-
Blunted cardiac reserve as a marker of cirrhotic cardiomyopathy—Cardiac outcomes following liver transplantation and comparison to the existing guidelines Am. J. Transplant. (IF 8.9) Pub Date : 2025-05-19
Benjamin Cailes, Eva-Louise Huber, Claudia Brick, Omar Farouque, Avik Majumdar, Ali Al-Fiadh, James Theuerle, Thalys S. Rodrigues, Terase Lancefield, Matias B. Yudi, Julian Yeoh, Adam Testro, Marie Sinclair, Anoop N. KoshyCirrhotic cardiomyopathy (CCM) is an underrecognized risk factor for cardiac events in patients undergoing liver transplantation (LT). Blunted cardiac reserve (BCR) is an emerging indicator of CCM, although it has not been integrated into diagnostic guidelines. This study assesses posttransplant cardiac outcomes and mortality in patients with BCR compared with current CCM diagnostic guidelines, focusing
-
Metabolic changes during cold ischemic preservation and reperfusion in porcine lung transplants Am. J. Transplant. (IF 8.9) Pub Date : 2025-05-17
Lubiao Liang, Michael K. Hsin, Yajin Zhao, Aizhou Wang, Tiago Machuca, Jonathan Yeung, Marcelo Cypel, Shaf Keshavjee, Mingyao LiuLung transplantation is a cornerstone in treating patients with end-stage lung disease, yet ischemia-reperfusion injury poses significant complications in posttransplant recovery. This study aimed to understand the effects of donor type, cold ischemic time (CIT), and reperfusion on metabolic changes in lung grafts. Porcine donor lungs underwent different CITs on ice: minimal time (control), 6 hours
-
Waitlist outcomes after acuity circle-based distribution in pediatric liver transplantation Am. J. Transplant. (IF 8.9) Pub Date : 2025-05-17
Denise J. Lo, Joseph F. Magliocca, Katherine Ross-DriscollPediatric liver transplant (LT) waitlist mortality remains unacceptably high. In 2020, the Organ Procurement and Transplantation Network implemented acuity circle (AC)-based liver distribution and national pediatric prioritization for pediatric donor livers. Using Organ Procurement and Transplantation Network data, waitlist outcomes for pediatric LT candidates listed between February 4, 2016, and February
-
Fatal acute respiratory distress syndrome caused by donor-derived human metapneumovirus after lung transplantation Am. J. Transplant. (IF 8.9) Pub Date : 2025-05-17
Solenne Hulot, Vincent Prunet, Benjamin Coiffard, Christine Zandotti, Céline Boschi, Xavier Benoit D’Journo, Sami Hraiech, Martine Reynaud-Gaubert, Philippe Colson, Nadim CassirRespiratory viral infections, including human metapneumovirus (hMPV), are increasingly recognized as a significant cause of morbidity and mortality in lung transplant recipients (LTRs). We present a case of hMPV pneumonia in a bilateral LTR, likely transmitted by the donor, resulting in severe acute respiratory distress syndrome and leading to death. Next-generation sequencing of hPMV genomes was performed
-
Supply, Distribution, and Aging of the General Surgeon Workforce by Rurality and Over Time: A National Observational Study. Ann. Surg. (IF 7.5) Pub Date : 2025-05-16
E Grace Petty,Robert D Luke,Alexa P Soult,Casey P BalioOBJECTIVE The purpose of this study is to estimate differences in the supply of general surgeons by age group and rurality and model potential impending shortages, with an emphasis on surgeons reaching and above the traditional retirement age. SUMMARY BACKGROUND DATA The healthcare workforce at large is experiencing shortages and impending retirements, which are especially prominent in rural communities
-
Trends in Surgical Quality at Critical Access Hospitals. Ann. Surg. (IF 7.5) Pub Date : 2025-05-16
Cody Lendon Mullens,Janice C Probst,Patrick L Johnson,Nicholas Kunnath,Justin B Dimick,Andrew M IbrahimOBJECTIVE To longitudinally compare trends in quality of care for common surgical conditions at CAHs compared to non-CAHs. SUMMARY BACKGROUND DATA Critical access hospitals (CAH) simultaneously face challenges of preserving access and ensuring quality. Data have identified concerns of quality over time for medical conditions, but less is understood about surgical care. DESIGN, SETTING, PARTICIPANTS
-
Daratumumab monotherapy as a desensitization strategy prior to cardiac transplantation. J. Heart Lung Transplant. (IF 6.4) Pub Date : 2025-05-16
Ruben J Crespo-Diaz,Adrian J daSilva-deAbreu,Andrew N Rosenbaum,Stacy A Bernard,Manish J Gandhi,Shaji Kumar,Taxiarchis Kourelis,Atta Behfar,Alfredo L Clavell,Shannon M Dunlay,Robert P Frantz,Sudhir S Kushwaha,Naveen L Pereira,Yee Weng Wong,Richard C Daly,Philip J Spencer,Mauricio A Villavicencio Theoduloz,Barry A BoilsonBACKGROUND Human leukocyte antigen (HLA) sensitization is a significant barrier to transplantation for many patients. Daratumumab has proven safety and tolerability in multiple myeloma. We hypothesized that daratumumab monotherapy could be an effective and safe desensitization strategy in highly sensitized patients awaiting cardiac transplantation. OBJECTIVES The primary end-point of this trial was
-
Optimal Pre-Transplant Duration with HeartMate III Left Ventricular Assist Device: A Contemporary Analysis. J. Heart Lung Transplant. (IF 6.4) Pub Date : 2025-05-16
Ahmet Bilgili,Iverson E Williams,Omar M Sharaf,Fabian Jimenez,Yuriy Stukov,Giles J Peek,Mark S Bleiweis,Jeffrey P Jacobs,Thomas M Beaver,Eric I JengBACKGROUND This study evaluates the impact of pretransplant HeartMate III (HM3) left ventricular assist device (LVAD) support duration on post-transplant survival in a contemporary cohort. METHODS A retrospective review of the United Network for Organ Sharing database was conducted for adult heart transplant recipients from January 2019 to December 2023 who were bridged with an HM3 LVAD. We utilized
-
Providing Equitable Surgical Care to Patients in Law Enforcement Custody JAMA Surg. (IF 15.7) Pub Date : 2025-05-14
Elinore J. Kaufman, Jesse E. Passman, Rucha Alur, Randi Smith, Anwar Osborne, Sara Scarlet, Kimberly Sue, Robert Wright, Rebecca Maine, Nephetari Smith, Nia Holston, Emily Zhu, Jessica H. BeardImportanceApproximately 2 million individuals are incarcerated in the US. Surgical needs increase with age, and an aging prison population means an increasing need for surgical care for incarcerated individuals. Challenges in logistics, privacy, communication, and comorbidities put people in law enforcement custody at risk for suboptimal care and outcomes. Little guidance exists for surgeons seeking
-
Role of Preoperative Antibiotic Treatment While Awaiting Appendectomy JAMA Surg. (IF 15.7) Pub Date : 2025-05-14
Karoliina Jalava, Ville Sallinen, Hanna Lampela, Hanna Malmi, Ingeborg Steinholt, Knut Magne Augestad, Ari Leppäniemi, Panu MentulaImportanceAntibiotics are thought to decelerate inflammation progression and reduce complications in acute uncomplicated appendicitis. The evidence of their effectiveness is insufficient, and treatment practices vary widely.ObjectiveTo investigate the effect of preoperatively started antibiotic treatment on the rate of appendiceal perforation.Design, Setting, and ParticipantsThis multicenter, noninferiority
-
Pancreatic Fistula After Minimally Invasive and Open Pancreaticoduodenectomy. JAMA Surg. (IF 15.7) Pub Date : 2025-05-14
Changhao Gao,Zhiyao Fan,Hanxiang Zhan -
Pancreatic Fistula After Minimally Invasive and Open Pancreatoduodenectomy. JAMA Surg. (IF 15.7) Pub Date : 2025-05-14
Max Judish,Charles M Vollmer -
Pancreatic Fistula After Minimally Invasive and Open Pancreatoduodenectomy-Reply. JAMA Surg. (IF 15.7) Pub Date : 2025-05-14
Caro L Bruna,Marc G Besselink,Mohammad Abu Hilal -
Failure Rate of Nonoperative Treatment of Appendicitis—Closer to 15% Than 50%? JAMA Surg. (IF 15.7) Pub Date : 2025-05-14
David A. Talan, Salomone Di SaverioThis Viewpoint outlines the problems with the failure rates for nonoperative treatment of uncomplicated appendicitis (NOTA) reported in several major trials and discusses why NOTA may be preferable to appendectomy.
-
Corrigendum to ''Disease characteristics, treatments, and outcomes of patients with pulmonary arterial hypertension treated with selexipag in real-world settings from the SPHERE registry (SelexiPag: tHe usErs dRug rEgistry)'' [J Heart Lung Transplant 43 (2024) 272-283]. J. Heart Lung Transplant. (IF 6.4) Pub Date : 2025-05-14
Vallerie McLaughlin,Harrison W Farber,Kristin B Highland,Anna R Hemnes,Murali M Chakinala,Kelly M Chin,Michelle Han,Michelle Cho,Tobore Tobore,Mohammad Rahman,Nick H Kim -
Measles update—United States, January 1–April 17, 2025 Am. J. Transplant. (IF 8.9) Pub Date : 2025-05-13
Marcus R. Pereira -
Letter in reference to “Long-term outcomes at 5 years post-transplant in imlifidase-desensitized kidney transplant patients” Am. J. Transplant. (IF 8.9) Pub Date : 2025-05-13
Carrie A. Schinstock, Mark Stegall -
Soluble CD95L is a prognostic marker in central nervous system posttransplant lymphoproliferative disorders Am. J. Transplant. (IF 8.9) Pub Date : 2025-05-13
Antoine Tichadou, Eden Lebrault, Assia Samri, Marine Baron, Cécilia Nakid-Cordero, David Lavergne, Véronique Morin, Oulfata Mze, Noureddine Balegroune, Xiaozhen Liang, Sylvain Choquet, Amélie Guihot, Patrick Legembre, Murielle Roussel, K-VIROGREF Study GroupCD95L is a transmembrane cytokine mainly expressed by activated T and natural killer cells to contract the immune response through cell-cell contact. Conversely, after cleavage by metalloproteases, this ligand releases a soluble CD95L (sCD95L) that stimulates the immune response and its antitumor activity. In posttransplant lymphoproliferative disorders (PTLDs), we hypothesized that the concentration
-
Unraveling CD8+ T cell alloimmunity: Insights into the direct pathway of antigen recognition from modern experimental tools Am. J. Transplant. (IF 8.9) Pub Date : 2025-05-13
Joel S. Freibaum, Riley P. Leathem, William Braaton, Scott M. KrummeyEarly experimental investigations of alloimmunity demonstrated that the T cell response against allogeneic antigens is robust and results from a high precursor frequency of responding clones. Seminal studies using cell culture-based methods led to an overall model in which CD8+ T cells can recognize self-peptide complexed to an allogeneic peptide major histocompatibility complex (MHC), termed the direct
-
Recommendations to overcome barriers to transplant fellowship training: A report from the American Society of Transplantation Fellows Task Force Am. J. Transplant. (IF 8.9) Pub Date : 2025-05-13
Jon Kobashigawa, Josh Levitsky, Neeraj Singh, Kiran Khush, Sean Pinney, Elizabeth Aby, Aasim Afzal, Deborah Adey, Anshul Bhalla, Mona Doshi, Samira Farouk, Alyson Fox, Shelley Hall, Michelle Kittleson, Lindsay King, Alexander Kuo, Deborah Levine, Yosef Manla, Jamak Modaresi, Arjmand Mufti, Prince Mohan Anand, Michael Nurok, J.P. Norvell, Neehar Parikh, Anjana Pillai, Faruq Pradhan, Allison Ramsey,With the expansion of solid organ transplantation activities in the United States, there is a critical need for more transplant care providers and trainees to sustain and advance the field of transplantation. However, there has been a pending shortage of trainees pursuing transplant fellowship training in the United States in recent years. To address this issue, the American Society of Transplantation
-
ACS NSQIP Risk Calculator Performance Across Multiple Domains of Operative Risk and Risk-associated Features. Ann. Surg. (IF 7.5) Pub Date : 2025-05-13
Mark E Cohen,Yaoming Liu,Bruce L Hall,Clifford Y KoOBJECTIVE To assess the accuracy of the ACS NSQIP Risk Calculator (RC) when applied to subsets of high-risk patients. BACKGROUND The RC plays an especially important role in surgical decision making in situations where probabilities for adverse events are high. However, the performance of the RC in these situations has not been studied in detail. Furthermore, past criticisms of the RC have evaluated
-
Trust but Verify: Should Trauma Surgeons Directly Interpret the Trauma CT Scan Images? Ann. Surg. (IF 7.5) Pub Date : 2025-05-13
Yasmin Arda,George Velmahos,Haytham Ma Kaafarani -
Correlation between Donor-Derived Cell-free DNA and Tissue Gene Expression in Heart Transplant Patients Undergoing for-cause Endomyocardial Biopsies. J. Heart Lung Transplant. (IF 6.4) Pub Date : 2025-05-13
Andrea Fernandez Valledor,Cathrine M Moeller,Daniel Oren,Julia Baranowska,Salwa Rahman,Adi Hertz,Afsana Rahman,Carolyn Hennecken,Gal Rubinstein,Boaz Elad,Ilan Richter,Dor Lotan,Matthew Regan,Brian LaBarre,Adil Yunis,Justin Fried,Ersilia M DeFilippis,Paolo C Colombo,Melana Yuzefpolskaya,Jayant Raihkelkar,Farhana Latif,Kevin D Clerkin,David T Majure,Gabriel T Sayer,Nir UrielINTRODUCTION The introduction of donor-derived cell-free DNA (dd-cfDNA) and the Molecular Microscope (MMDx) is changing how we diagnose rejection following heart transplantation (HT). This study aims to assess the accuracy of dd-cfDNA in detecting rejection as identified by MMDx and histology, with a focus on determining an optimal dd-cfDNA threshold to improve diagnostic performance. METHODS Single-center
-
Donor-specific mesenchymal stem cell infusion in human and nonhuman primate kidney transplantation Am. J. Transplant. (IF 8.9) Pub Date : 2025-05-12
Imran J. Anwar, Shu Li, Michael Mulvihill, Robin Schmitz, Brian Shaw, Qimeng Gao, Sherri Swan-Nesbit, Lynn A. Cheatham, Tam How, Allison Miller, Kyha Williams, Fang-Fang Yin, William Giles, Joanne Kurtzberg, Sindhu Chandran, Nancy Bridges, Lyudmila Lyakh, Cynthia Breeden, Krupa Gandhi, Michelle Sever, Mingqing Song, Xu He, Allan D. KirkWe report the results of 2 independent, concurrently performed studies evaluating the safety and efficacy of donor-derived mesenchymal stromal cell (MSC) infusions in inducing immune-tolerance in nonhuman primate (NHP) and human kidney transplant recipients treated with depletional induction and belatacept/sirolimus maintenance. Fifteen NHPs received rhesus ATG induction and were divided into 3 groups:
-
Acetylcholine from B lymphocytes orchestrates liver regeneration Am. J. Transplant. (IF 8.9) Pub Date : 2025-05-12
Christopher Bricogne, Fadi Issa -
The short end of the stick: Access to lung transplantation for short-statured patients in the composite allocation score era Am. J. Transplant. (IF 8.9) Pub Date : 2025-05-12
Isaac S. Alderete, Alexandria L. Soto, Samantha E. Halpern, Arya Pontula, Ewout Muylle, Kentaro Nakata, Kunal J. Patel, Jacob Klapper, Matthew G. HartwigShort-statured lung transplant candidates experience longer waitlist times than taller ones. The new composite allocation score (CAS) includes height to enhance allocation equity. We assessed the impact of CAS on waitlist outcomes for different height groups. We queried a national transplant database for lung transplant candidates listed from 2021 to 2024, categorized into 4 height groups: ≤162 cm
-
Beyond the HIV Organ Policy Equity Act: Roadmap to expanding kidney and liver transplants for people with human immunodeficiency virus utilizing grafts from donors with human immunodeficiency virus Am. J. Transplant. (IF 8.9) Pub Date : 2025-05-12
Tzu-Hao Lee, Kara Wegermann, Ken Sutha, George Cholankeril, Chia-Yu Chiu, Nhu Thao Nguyen Galvan, Abbas Rana, John A. Goss, Tyler Lambing, Felice Cinque, Giada Sebastiani, Keyur Patel, Susanna Naggie, Cameron R. WolfePeople living with human immunodeficiency virus (HIV) (PWH) face limited access to organ transplantation despite higher rates of end-organ disease. The HIV Organ Policy Equity Act, enacted in 2015, allowed transplants from donors with HIV to recipients with HIV (HIV D+/R+) under research protocols. Studies have since demonstrated overall comparable outcomes between HIV D+/R+ and donors without HIV/R+
-
Graft biopsy reimagined: Integrating morphology and molecular maps Am. J. Transplant. (IF 8.9) Pub Date : 2025-05-09
Umberto Maggiore, Paolo Cravedi -
Back-table intra-arterial administration of C1 esterase inhibitor to deceased donor kidney allografts improves posttransplant allograft function: Results of a randomized double-blind placebo-controlled clinical trial Am. J. Transplant. (IF 8.9) Pub Date : 2025-05-09
Edmund Huang, Noriko Ammerman, Ashley Vo, Jean Hou, Sanjeev Kumar, Nicole Badash, Ben Falk, Kathleen Hernando, Matthew Gillespie, Irene K. Kim, Kathlyn Lim, Reiad Najjar, Alice Peng, Bongha Shin, Justin A. Steggerda, Tsuyoshi Todo, Todd V. Brennan, Georgios Voidonikolas, Steven A. Wisel, Peter S. Heeger, Stanley C. JordanIschemia-reperfusion injury commonly causes delayed graft function (DGF) after kidney transplantation and is associated with poorer graft function and lower allograft survival. Activation of the lectin complement pathway is one mediator of ischemia-reperfusion injury. In this randomized double-blind placebo-controlled pilot study, we tested whether preimplantation intragraft administration of C1 esterase